ARUP Labs Partners with CDC to Develop H5N1 Test
ARUP Laboratories has been selected by the CDC to develop a rapid-response test for H5N1, addressing the ongoing public health crises.
ARUP Laboratories has been selected by the CDC to develop a rapid-response test for H5N1, addressing the ongoing public health crises.
Virax Biolabs secured a distribution agreement to commercialize Mpox detection kits across Europe and for Gulf Cooperation Council nations.
A new study found routine lab tests may not effectively diagnose long COVID, underscoring the need for new biomarkers and diagnostic tools.
Researchers developed a test for early detection of T. cruzi infection in newborns, showing promise for better management of Chagas disease.
Researchers developed a smartphone-controlled centrifugal microfluidic device that rapidly detects different subtypes of the influenza virus.
New C. diff testing guidelines lead to a significant reduction in inappropriate testing by 20%, which helped decrease overtreatment.
Researchers developed a new lab test to detect intact HIV infections with African strains, crucial for advancing global HIV cure efforts.